AMARIN CORP PLC\UK - FORM 10-K - EX-21.1 - February 27, 2018

Attached files

file filename
10-K - 10-K - AMARIN CORP PLC\UKamrn-10k_20171231.htm
EX-32.1 - EX-32.1 - AMARIN CORP PLC\UKamrn-ex321_9.htm
EX-31.2 - EX-31.2 - AMARIN CORP PLC\UKamrn-ex312_8.htm
EX-31.1 - EX-31.1 - AMARIN CORP PLC\UKamrn-ex311_10.htm
EX-23.1 - EX-23.1 - AMARIN CORP PLC\UKamrn-ex231_11.htm
EX-10.68 - EX-10.68 - AMARIN CORP PLC\UKamrn-ex1068_470.htm
EX-10.67 - EX-10.67 - AMARIN CORP PLC\UKamrn-ex1067_469.htm
EX-10.66 - EX-10.66 - AMARIN CORP PLC\UKamrn-ex1066_210.htm
EX-10.64 - EX-10.64 - AMARIN CORP PLC\UKamrn-ex1064_140.htm

 

EXHIBIT 21.1

Subsidiaries of the Registrant as of December 31, 2017

 

 

 

Name

 

Jurisdiction

 

Amarin Pharmaceuticals Ireland Limited

Ireland

Amarin Pharma, Inc.

Delaware

Amarin Neuroscience Limited

Scotland

Corsicanto DAC (in liquidation) (formerly Corsicanto Limited)

Ireland

Corsicanto II DAC

Ireland

Ester Neurosciences Limited

Israel

 

 

AMARIN CORP PLC\UK Reports